Clearwater Denmark advises M&J Airlaid Products on its sale to Mölnlycke

Transaction

M&J Airlaid Products sold to Mölnlycke

Sell-side

Undisclosed

Role

Adviser to M&J Airlaid Products on its sale to Mölnlycke

Sector

Healthcare

Region

Denmark

Clearwater Denmark has advised M&J Airlaid Products (M&J), a world-leading manufacturer of specialised and high-quality absorbent airlaid non-woven materials, on its sale to Mölnlycke.

M&J develops products for the advanced wound care and hygiene industries. Significant product knowledge, strong research and development capabilities, has enabled it to secure long term relationships with global healthcare OEM customers. The M&J products are vital core components in products for advanced wound care, dressing, surgery, burn treatment, incontinence pads and dental hygiene.

Mölnlycke, founded in 1849 and with headquarters in Gothenburg, Sweden are a world leading medical solutions company. They develop and supply wound care and surgical solutions across the entire spectrum – from prevention to post-acute care. Mölnlycke employ 7,800 people around the world and generate revenue in excess of €1.4bn.

From the outset, the ambition was to find a long-term partner to care for our heritage and Clearwater has assisted us in finding just that. Selling a business is a complex process and the team at Clearwater used their invaluable strategic experience to support me in navigating through the sale. The team managed the process in a timely and efficient manner, making sure that all stakeholders received the necessary and relevant information at the right time, allowing our organisation to focus on our customers and day to day operations. In Mölnlycke, a long-time customer and partner of M&J, we have found a strong strategic partner with values that match our own, and I look forward to continued success under the new ownership structure.
Jens Ole Brøchner Andersen, CEO, M&J Airlaid Products

Mölnlycke’s acquisition of M&J is yet another example of a large OEM focusing their power on the most critical parts of the supply chain in order to decrease supply risk, and gain competitive advantages in the market. It has been a pleasure advising M&J, whilst carefully navigating this unique process of vertical integration. With M&J’s strong R&D capabilities, Mölnlycke will improve its future competitive position significantly in the global advanced wound care market. We look forward to seeing the synergies unfold in this new partnership.
Per Surland, Partner, Clearwater Denmark

The Danish healthcare market from an M&A perspective, remains highly attractive despite the recent turmoil in the financial markets. Underlying market trends such as an ageing population, stable growth expectations and increasing scope for public procurement, combined with its less cyclical nature and high entry barriers makes it an attractive segment for both strategic consolidators and financial acquirers.
Jesper Agerholm, Director and Head of Healthcare, Clearwater Denmark